Stock screenerAll disclosures →
EDGAR →
BMRN
Conviction 48HealthcareScan · Fri, Jun 26, 2026BMRN$59.02+2.90%
ResistanceSupportVol 14Insider sellVol MA14 2.45M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price59.02
Change+2.90%
Gap-0.31%
Rel volume3.11×
Avg volume2.6M
Avg $ vol146.55M
SMA 2056.11
SMA 5054.45
SMA 20055.67
Price vs 50+8.38%
Price vs 200+6.01%
MA stackmixed
50/200 cross—
Supertrendup · 53.38
RSI (14)64
MACD hist0.25
MACD crossbull · 3d
Stoch %K / %D87 / 80
ADX (14)24
+DI / −DI32 / 13
RSI divergenceBearish
MACD divergence—
ATR %+2.86%
ADR %3.03%
52w high64.08
52w low49.67
From 52w high-7.90%
Above 52w low+18.81%
New 52w highNo
SqueezeOff
Bollinger width9.14%
%B1.07
Donchian pos89.09%
Donchian high59.75
Donchian low53.01
AVWAP (52w high)55.84
vs AVWAP high+5.69%
AVWAP (52w low)55.10
vs AVWAP low+7.11%
OBV trendUp
Chaikin MF (20)0.11
Today vs 20d3.11×
Avg vol (14d)2.45M
Avg vol (20d)2.6M
Avg $ vol (20d)146.55M
Market cap—
RS 3m (vs SPY)-8.63%
RS 6m (vs SPY)-10.48%
RS line new highNo
Trend template4/8
Technical rank63.0
1 week+7.91%
1 month+12.67%
3 months+6.24%
6 months-3.48%
1 year+9.00%
YTD-0.73%
P/E31.78
P/B1.78
P/S3.44
P/FCF15.29
EPS1.80
Div yield—
ROE5.62%
ROA4.06%
Debt/Eq0.23
Current5.81
EV/EBITDA21.05
Gross margin—
Net margin10.83%
Rev growth12.87%
EPS growth-18.26%
Price target87.00
Target upside51.67%
Analyst ratingBuy
Institutional109.33%
Ent. value10.29B
Revenue766.21M
Net income105.53M
Gross profit—
Free cash flow724.96M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out193.28M
Employees3.22K
ListedFri, Jul 23, 1999
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction48 / 100
Pattern quality—
Tech rank63.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance57.89
Support50.73
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BMRN
No recent disclosed trades by Congress in BMRN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BMRN · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Dere Willard H Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
ANDERSON ELIZABETH M Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Ho Maykin Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Walbert Timothy P Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
CLARK IAN T Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Countouriotis Athena Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Walbert Timothy P Director · Common Stock · 2026-06-02 | Other | — | — | 2026-06-02 | 2026-06-04 |
Enyedy Mark J Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Bodem Barbara W. Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
HOMBACH ROBERT J. Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
SEC filings
EDGAR filings in BMRN · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.